Title
Ordinance amending the South San Francisco Zoning Map to include additional properties within the Genentech Master Plan District.
body
WHEREAS, in 2020, the City of South San Francisco ("City") adopted (1) Resolution No. 169-2020 certifying the Environmental Impact Report, including adoption of the Statement of Overriding Considerations and the Mitigation Monitoring and Reporting Program, for the Genentech 2020 Master Plan Update (State Clearinghouse No. 2017052064, (2) Resolution No. 170-2020 adopting the Genentech 2020 Master Plan Update, and (3) Ordinance No. 1614-2020 amending Chapter 20.260 of the South San Francisco Municipal Code related to the Genentech Master Plan Zoning District; and
WHEREAS, the Genentech 2020 Master Plan guides the development of the Genentech campus over a period of fifteen (15) years to create a vibrant, transit supported, state of the art research, office, and manufacturing campus for the life sciences; and
WHEREAS, Genentech, Inc. ("Owner" or "Applicant") has submitted an application requesting acquisition of certain public rights-of-way (DNA Way, Point San Bruno Boulevard, and Cabot Road) within the Genentech Campus Master Plan boundaries, and to add the vacated streets and private properties at 333 Point San Bruno Boulevard (APNs 015-250-410 and 015-250-140), 525 DNA Way (APN 015-250-210), and 383-393 East Grand Avenue (APN 015-250-390) to the Genentech Campus Master Plan ("Project"); and
WHEREAS, the Applicant has proposed amendments to the Genentech 2020 Master Plan, adopted by the City Council by separate Resolution, to incorporate the new private parcels and to reflect the ability to close the public roadways to public through traffic once certain conditions are met; and
WHEREAS, the General Plan contains several goals, policies, and actions which support the sale of DNA Way, Point San Bruno Boulevard, and a segment of Cabot Road, in the interest of ensuring Genentech remains a premier biotechnology campus, prioriti...
Click here for full text